These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 14727004)
1. Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study. Morgan CJ; Mofeez A; Brandner B; Bromley L; Curran HV Psychopharmacology (Berl); 2004 Mar; 172(3):298-308. PubMed ID: 14727004 [TBL] [Abstract][Full Text] [Related]
2. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Curran HV; Morgan C Addiction; 2000 Apr; 95(4):575-90. PubMed ID: 10829333 [TBL] [Abstract][Full Text] [Related]
3. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Curran HV; Monaghan L Addiction; 2001 May; 96(5):749-60. PubMed ID: 11331033 [TBL] [Abstract][Full Text] [Related]
4. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Morgan CJ; Monaghan L; Curran HV Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Morgan CJ; Mofeez A; Brandner B; Bromley L; Curran HV Neuropsychopharmacology; 2004 Jan; 29(1):208-18. PubMed ID: 14603267 [TBL] [Abstract][Full Text] [Related]
6. Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys. Sun L; Li Q; Li Q; Zhang Y; Liu D; Jiang H; Pan F; Yew DT Addict Biol; 2014 Mar; 19(2):185-94. PubMed ID: 23145560 [TBL] [Abstract][Full Text] [Related]
7. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Hetem LA; Danion JM; Diemunsch P; Brandt C Psychopharmacology (Berl); 2000 Oct; 152(3):283-8. PubMed ID: 11105938 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Morgan CJ; Riccelli M; Maitland CH; Curran HV Drug Alcohol Depend; 2004 Sep; 75(3):301-8. PubMed ID: 15283951 [TBL] [Abstract][Full Text] [Related]
9. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Morgan CJ; Muetzelfeldt L; Curran HV Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593 [TBL] [Abstract][Full Text] [Related]
10. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331 [TBL] [Abstract][Full Text] [Related]
11. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Morgan CJ; Muetzelfeldt L; Curran HV Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891 [TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia? Stefanovic A; Brandner B; Klaassen E; Cregg R; Nagaratnam M; Bromley LM; Das RK; Rossell SL; Morgan CJ; Curran HV J Clin Psychopharmacol; 2009 Apr; 29(2):124-33. PubMed ID: 19512973 [TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of ketamine upon human memory: a review. Morgan CJ; Curran HV Psychopharmacology (Berl); 2006 Nov; 188(4):408-24. PubMed ID: 17006715 [TBL] [Abstract][Full Text] [Related]
14. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299 [TBL] [Abstract][Full Text] [Related]
15. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Morgan CJ; Rossell SL; Pepper F; Smart J; Blackburn J; Brandner B; Curran HV Biol Psychiatry; 2006 Feb; 59(3):265-72. PubMed ID: 16140283 [TBL] [Abstract][Full Text] [Related]
17. Pre-exposure to related substances induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, zoletil. de la Peña JB; Yoon SY; de la Peña IC; Lee HL; I de la Peña IJ; Cheong JH Behav Pharmacol; 2013 Feb; 24(1):20-8. PubMed ID: 23238086 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242. Ranganathan M; DeMartinis N; Huguenel B; Gaudreault F; Bednar MM; Shaffer CL; Gupta S; Cahill J; Sherif MA; Mancuso J; Zumpano L; D'Souza DC Mol Psychiatry; 2017 Nov; 22(11):1633-1640. PubMed ID: 28242871 [TBL] [Abstract][Full Text] [Related]
19. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L Encephale; 2001; 27(1):53-9. PubMed ID: 11294039 [TBL] [Abstract][Full Text] [Related]
20. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]